Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 91-97

  Jiménez, Pilar ^a   Cantón, Julia ^a   Collado, Antonia ^a   Cabrera, Teresa ^a   Serrano, Alfonso ^a   Real, Luis Miguel ^a   García, Angel ^a   Ruiz Cabello, Francisco ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; MICROSATELLITE DNA;

ANTIGEN EXPRESSION; ARTICLE; CELL SURVIVAL; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME LOSS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA DETERMINATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL;

EID: 0345466640     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<91::AID-IJC17>3.3.CO;2-W     Document Type: Article

References (39)

1. BARNSTABLE, C.J., BODMER, W.F., BROWN, G., GALFRE, B.B., MILSTEIN, C., WILLIAMS, A.F. and ZIEGLER, A., Production of monoclonal antibodies to group A ery throcyte HLA and other human cell surface antigens. New tools for genetic analysis. Cell, 14, 9-20 (1978).
2. BENITEZ, R. and 12 OTHERS, Mutations of β2-microglobulin gene result in lack of HLA class 1 molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens, 52, 520-529 (1998).
3. BRANCH, P., BICKELL, D.C., ROWAN, A., BODMER, W.F. and KARRAN, P., Immune surveillance in colorectal carcinoma. Nature Genet., 9, 231-232 (1995).
4. BROWNING, M.J., KRAUSA, P., ROWANS, A., BICKNELL, D.C., BODMER, J.G. and BODMER, W., Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. nat. Acad. Sci. (Wash.), 90, 2842-2845 (1993).
5. BURRONE, O.R., KEFFORD, R.F., GILMORE, D. and MILSTEIN, C., Stimulation of HLA ABC by viral IFN. The derivation of Molt4 variant and the differential expression of HLA ABC subset. EMBO J., 4, 2855-2690 (1985).
6. CABRERA, T., COLLADO, A., FERNANDEZ, M.A., FERRON, A., SANCHO, J., RUIZ-CABELLO, F. and GARRIDO, F., High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens, 52, 114-123 (1998).
7. CABRERA, T., RUIZ-CABELLO, F., LOPEZ-NEVOT, M.A., DE LA HIGUERA, B., SANCHEZ, M. and GARRIDO, F., Characterization of monoclonal antibodies against HLA class II molecules. Hybridoma, 5, 191-196 (1986).
8. DE NOOIJ-VAN DALEN, A.G., VAN BUUREN-VAN SEGGLEN, V.H., LOHMAN, P.H. and GIPHART-GASSLER, M., Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro. Genes Chromosomes Cancer, 21, 30-38 (1998).
9. FOISSAC, A., CROUAU-ROY, B., FAURE, S., THOMSEN, M. and CAMBON-THOMSEN, A., Microsatellites in HLA region: an overview. Tissue Antigens, 49, 197-214 (1997).
10. GARRIDO, F. and 21 OTHERS, HLA and cancer. In: D. Charron (ed.), HLA. Genetic diversity of HLA. Functional and medical implication. Vol. I, pp. 445-452, EDK, Paris (1997a).
11. GARRIDO, F., CABRERA, T., CONCHA, A., GLEW, S., RUIZ-CABELLO, F. and STERN, P., Natural history of HLA expression during tumor development. Immunol. Today, 14, 491-493 (1993).
12. GARRIDO, F., CABRERA, T., LOPEZ-NEVOT, M.A. and RUIZ-CABELLO, F., HLA class I antigens in human tumors. Advanc. Cancer Res., 67, 155-195 (1995).
13. GARRIDO, F., RUIZ-CABELLO, F., CABRERA, T., PEREZ-VILLAR, J.J., LOPEZ-BOTET, M.A., DUGGAN-KEEN, M. and STERN, P., Implications for immuno-surveillance of altered HLA class I phenotypes in human tumors. Immunol. Today, 18, 89-95 (1997b).
14. GRUIS, N.A., ABELN, E.C., BARDOEL, A.F., DEVILEE, P., FRANTS, R.R. and CORNELISSE, C.J., PCR-based microsatellite polymorphism in the detection of loss of heterozygosity in fresh and archival tumour tissue. Brit. J. Cancer, 68, 308-313 (1993).
15. GYAPAY, G., MORISETTE, J., VIGNAL, A., DIB, C., FIZAMES, C., MILLASSEAU, P., MARC, S., BERNARDI, G., LATHROP, M. and WEISSENBACH, J., The 1993-1994 Genethon human genetic maps. Nature Genet., 7, 246-249 (1994).
16. HEALY, E., BELGAID, C., TAKATA, M., HARRISON, D., ZHU, N.W., BURD, D.A., RIGBY, H.S., MATTHEWS, J.N. and REES, J.L., Prognostic significance of allelic losses in primary melanoma. Oncogene, 16, 2213-2218 (1998).
17. HUTTER, R., Worldwide agreement of the staging of cancer. Arch. Surg., 122, 1235-1246 (1987).
18. JÄGER, E., RINGHOFFER, M., ALTMANNSBERGER, M., ARAND, M., KARBACH, J., JÄGER, D., OESCH, F. and KNUTH, A., Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer, 71, 142-147 (1997).
19. JARES, P., FERNANDEZ, P.L., NADAL, A., CAZORLA, M., HERNANDEZ, L., PINYOL, M., HERNANDEZ, S., TRASERRA, J., CARDESA, A. and CAMPO, E., p16MTS1/CDK41 mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous-cell carcinoma of the larynx. Oncogene, 15, 1445-1453 (1997).
20. JEN, J., KIM, H., PIANTADOSI, S., LIU, Z.F., LEVITT, R.C., SISTONEN, P., KINZLER, K.W., VOGELSTEIN, B. and HAMILTON, S.R., Allelic loss of chromosome 18q and prognosis in colorectal cancer. New Engl. J. Med., 331, 213-221 (1994).
21. LEE, J.Y., DONG, S.M., SHIM, M.S., KIM, S.Y., LEE, S.H., KANG, S.J., LEE, J.D., KIM, C.S., KIM, S.H. and YOO, N.J., Genetic alterations of p161NK4a and p53 genes in sporadic dysplastic nevus. Biochem. biophys. Res. Commun., 237, 667-672 (1997).
22. LEHMANN, F., MARCHAND, M., HAINAUT, P., POUILLART, P., SASTRE, X., IKEDA, H., BOON, T. and COULIE, P.G., Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Europ. J. Immunol., 25, 340-347 (1995).
23. LOPEZ-NEVOT, M.A., CABRERA, T., DE LA HIGUERA, B., RUIZ-CABELLO, F. and GARRIDO, F., Production and characterization of monoclonal antibodies against leukemic cells. Inmunología, 5, 51-59 (1986).
24. LOZANO, F., SANTOS-AGUADO, J., BORCHE, L., PLACES, L., DOMENECH, N., GAYA, A., VILELLA, R. and VIVES, J., Identification of the amino acid residues defining an intralocus determinant in the β1 domain of HLA-A molecules. Immunogenetics, 30, 50-53 (1989).
25. MARINCOLA, F.M., SHAMANIAN, P., ALEXANDER, R.B., GNARRA, J.R., TURETSKAYA, R.L., NEDOSPASOV, S.V., SIMONIS, T.B., TAUBENBERGER, J.K., YANELLI, J. and MIXON, A., Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153, 1225-1237 (1994).
26. MILLER, S.A., DYKES, D.D. and POLESKY, H.F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215 (1988).
27. MULLOKANDOV, M.R., KHOLODILOV, N.G., ATKIN, N.B., BURK, R.D., JOHNSON, A.B. and KLINGER, H.P., Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res., 56, 197-205 (1996).
28. OGUNBIYI, O.J., GOODFELLOW, P.J., HERFATH, K., GAGLIARDI, G., SWANSON, P.E., BIRBAUM, E.H., READ, T.E., FLESHMAN, J.W., KODNER, I.J. and MOLEY, J.F., Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J. clin. Oncol, 16, 427-433 (1998).
29. OHTA, M., BERD, D., SHIMIZU, M., NAGAI, H., COTTICELLI, M.G., MASTRANGELO, M., SHIELDS, J.A., SHIELDS, C.L., CROCE, C.M. and HUEBNER, K., Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int. J. Cancer, 65, 762-767 (1996).
30. PLOEGH, H.L., Viral strategies of immune evasion. Science, 280, 248-253 (1998).
31. REAL, L.M., JIMÉNEZ, P., CANTÓN, J., KIRKIN, A.F., GARCÍA, A., ABRIL, E., ZEUTHEN, A., RUIZ-CABELLO, F. and GARRIDO, F., In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumor cell variants expressing a single HLA class I allele. Int. J. Cancer, 75, 317-323 (1998).
32. ROWLEY, H., JONES, A.S. and FIELD, J.K., Chromosome 18: a possible site for a tumor suppressor gene deletion in squatnous cell carcinoma of the head and neck. Clin. Otolaryngol., 20, 266-271 (1995).
33. RUIZ-CABELLO, F. and GARRIDO, F., HLA and cancer: from research to clinical impact. Immunol. Today, 19, 539-542 (1998).
34. SHIBATA, D., REALE, M.A., LAVIN, P., SILVERMAN, M., FEARON, E.R., STEELE, G., JESSUP, J.M., LODA, M. and SUMMERHAYES, I.C., The DCC protein and prognosis in colorectal cancer. New Engl. J. Med., 335, 1727-1732 (1996).
35. SPEAR, B.T., KORBLUTH, J., STROMINGER, J.L. and WILSON, D.B., Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody A131. J. exp. Med., 162, 1802-1810 (1985).
36. TOMLINSON, I. and BODMER, W., Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Med., 5, 11-12 (1999).
37. TORRES, M., RUIZ-CABELLO, F., SKOUDY, A., BERROZPE, G., SERRANO, A., JIMÉNEZ, P., REAL, F.X. and GARRIDO, F., Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens, 47, 372-381 (1996).
38. WALKER, G.J., PALMER, J.M., WALTERS, M.K., NANCARROW, D.J., PARSONS, P.G. and HAYWARD, N.K., Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma. Int. J. Cancer, 58, 203-206 (1994).
39. WEBER, J.L., KWITEK, A. and MAY, P.E., Dinucleotide repeat polymorphism at the D6S87 locus. Nucleic Acids Res., 18, 4636 (1990).